Ecosystem · Lifecycle coverage
Full ecosystem lifecycle coverage.
Module ownership and build status across the entire drug-development value chain — every stage on one engine, governed end-to-end by HAIOps.
Active
Partial
v0.1 drafted
Early build
Roadmap
Partner
Value chain →
Scroll horizontally →
Discovery
Diagen
Partner
Target ID & hit discovery. External partner — not Hakase-built.
Pre-clinical
BioDigital Twin
Active
Zero-Lab cascade L1 → L2 → L3. Predict-then-confirm vs customer lab.
Clinical
Clinical
Partial
Phases 2–4 on roadmap. Phase 1 folded into the Twin.
CMC
—
Roadmap
Manufacturing & controls. Not yet scoped.
Regulatory
RIM
v0.1 drafted
GCC = first cartridge. Authoring · IM · Insights.
Quality
—
Roadmap
QMS / GxP quality. Not yet scoped.
Medical Affairs
Medical
Early build
Renamed from Clinical Ext. MSL · evidence · KOL.
Marketing & Growth
Commz
Active
Commercial / M&G module. Brand · launch · growth.
Patient / Care
Care
Active
Patient engagement & RWE. Care platform module.
GCC product lines · v0.1 drafted
RIM (regulatory) · PV (pharmacovigilance) · HEOR (value & market access) — the GCC-region wedge, English submissions.
HAIOps — orchestration & governance layer
Spans every module
Orchestration
Hybrid orchestrated-swarm model.
Gate Service
Falsifier registry · dispatch · escalation · audit · governance.
Digital Workforce
35 specialist agents · 4 domain swarms + 4 twin curators.
Delivery model — DAaaS: per-deliverable · per-stage · per-trial. Privacy-first — the engine never trains on customer program data.
Entity structure
AKTHealth
Owns the platform + BioDigital Twin; runs the in-silico predict-then-confirm engine.
AKTBio
Separate out-licensing entity; holds asset IP. Does not run Phase 1+ clinical or commercial.
Diagen
Discovery partner — target ID / hit-finding. External.